European stocks that trade on US exchanges slipped late Thursday morning, with the S&P Europe Select ADR Index falling 0.58% to 1,962.65. The decline was led by weakness in healthcare heavyweights Novo Nordisk and Sanofi, while software names Materialise and SAP managed to post gains.
ADRs, or American depositary receipts, are a way for US investors to buy shares of foreign companies without dealing with overseas exchanges. Each ADR represents a certain number of shares in the underlying company, and they trade on US markets just like domestic stocks. The S&P Europe Select ADR Index tracks a basket of these instruments, giving a snapshot of how European equities are performing in the US session.
What's driving the move?
The index's decline was not uniform. While the overall benchmark fell, a couple of names stood out on the upside. Materialise, a Belgian 3D printing software company, and SAP, the German enterprise software giant, both traded higher. On the other side, Novo Nordisk, the Danish pharmaceutical company known for its diabetes and weight-loss drugs, and Sanofi, the French drugmaker, were among the laggards.
Healthcare has been a volatile sector recently, with investors weighing everything from drug pricing pressures to the competitive landscape in weight-loss treatments. Novo Nordisk, in particular, has been a major focus for investors given its dominance in the GLP-1 market, but any news about competition or regulatory changes can move the stock sharply. Sanofi, meanwhile, has been navigating its own pipeline and patent challenges.
The broader European market has been mixed this week, with investors keeping an eye on corporate earnings, central bank policy, and geopolitical developments. Earlier in the week, European stocks were flat as Nvidia lifted tech shares while oil slipped on talks between Iran and Qatar. That kind of crosscurrent has been typical, with tech and energy pulling in opposite directions.
Why the index move can be misleading
On days like this, the headline index move can hide a tug-of-war underneath. Smaller stocks can post big percentage gains without moving the benchmark much, because cap-weighted indexes give the largest companies the most influence. That means a 1% drop in a giant like Novo Nordisk can outweigh a 5% jump in a smaller name like Materialise.
For everyday investors, this is a reminder that index moves don't tell the whole story. If you own individual ADRs, your portfolio's performance may differ significantly from the index, depending on which companies you hold. Diversification across sectors and regions can help smooth out these swings.
What it means for investors
For US investors with exposure to European stocks, Thursday's slip is a modest pullback after a period of relative strength. The index remains near recent levels, and a 0.58% move is well within normal daily volatility. Still, it's worth watching whether healthcare weakness persists, as that sector carries heavy weight in European indexes.
Investors should also keep an eye on the broader macro backdrop. European economic data has been mixed, with German growth and a business sentiment uptick recently lifting stocks. But concerns about inflation, interest rates, and global trade remain.
For those considering European ADRs, it's important to understand the currency angle. ADR prices are influenced by both the underlying stock's performance and the exchange rate between the euro (or other European currencies) and the US dollar. A stronger dollar can weigh on ADR returns, even if the underlying stock is flat.
As always, moves like this are part of the normal ebb and flow of markets. Rather than reacting to a single day's decline, investors should focus on their long-term goals and the fundamentals of the companies they own. If you're looking for exposure to European markets, ADRs offer a convenient way to do so, but they come with their own risks, including currency fluctuations and geopolitical events.
For more on how European stocks are trading, check out our earlier coverage of European ADRs staying flat as biotech gains offset declines in banks and oil. And for a look at how individual sectors are moving, see our piece on biotech swings splitting European ADRs.
Overall, Thursday's dip is a reminder that markets don't move in straight lines. Even on down days, there are winners and losers, and understanding the drivers behind the moves can help you make more informed decisions.
